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Abstract
Aim An anastomotic leak after surgery for colon cancer
is a recognized complication but how it may adversely
affect long-term survival is less clear because data are
scarce. The aim of the study was to investigate the
long-term impact of Grade C anastomotic leak in a
large, population-based cohort.
Method Data on patients undergoing resection for
Stage I–III colon cancer between 2008 and 2012 were
collected from the Swedish, Norwegian and Danish
Colorectal Cancer Registries. Overall relative survival
and conditional 5-year relative survival, under the con-
dition of surviving 1 year, were calculated for all
patients and stratified by stage of disease.
Results A total of 22 985 patients were analysed.
Anastomotic leak occurred in 849 patients (3.7%).
Five-year relative survival in patients with anastomotic
leak was 64.7% compared with 87.0% for patients
with no leak (P < 0.001). Five-year relative survival
among the patients who survived the first year was
88.6% vs 81.3% (P = 0.003). Stratification by cancer
stage showed that anastomotic leak was significantly
associated with decreased relative survival in patients
with Stage III disease (P = 0.001), but not in patients
with Stage I or II (P = 0.950 and 0.247, respec-
tively).
Conclusion Anastomotic leak after surgery for Stage III
colon cancer was associated with significantly decreased
long-term relative survival.
Keywords Colon cancer, anastomotic leak, relative sur-
vival, surgery, colorectal cancer registries
What does this paper add to the literature?
Cancer-specific survival after surgery for colon cancer is
not well addressed in the literature. Cancer-specific sur-
vival is expressed by national cancer registries using rela-
tive survival as the default approach. This study shows
that anastomotic leak is associated with significantly
reduced long-term relative survival in patients with
Stage III colon cancer.
Introduction
The aim of surgery in the management of colon cancer
is to cure the disease without the need for a permanent
stoma. Most will undergo a restorative procedure with
an ileo-colonic or colo-colonic anastomosis but with an
inherent risk of anastomotic leak which not only may
harm the patient in the short term but also may affect
outcomes over time [1–4]. Long-term survival is con-
sidered a key indicator for monitoring the effectiveness
of cancer treatment as well as health services in general
[5,6].
Anastomotic leak has specifically been reported to
increase short- and long-term morbidity and mortality
[3,4,7–10]. There are fewer data on the impact of anas-
tomotic leak on long-term oncologic outcome. A recent
review and meta-analysis concluded that there are only
a limited number of publications which address colon
cancer surgery, most studies investigated rectal cancer
and colorectal cancer combined [11]. Only four out of
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31 studies on anastomotic leak dealt with colon cancer.
None reported cancer-specific survival, considered as a
crucial measure of the effect of cancer treatment for
cure. Moreover, there is little information on the impact
of anastomotic leak applied to the different stages of
colon cancer.
The incidence of anastomotic leak after colonic
resection is reported to be between 3% and 5% [12]. As
a consequence, large patient cohorts are required to
provide data with sufficient statistical power in the
long-term analysis of outcomes [9]. This is particularly
true for subgroup analyses such as stage of disease.
Large population-based studies may contribute to a bet-
ter understanding.
In Sweden, Norway and Denmark, public healthcare
systems are organized according to the common princi-
ple of free and equal healthcare services to all citizens
regardless of social status and income. The Scandinavian
national guidelines for diagnosis and treatment of colon
cancer (preoperative studies, the obligatory use of mul-
tidisciplinary team meetings and adjuvant treatment for
Stage III disease) are highly comparable. The Colorectal
Cancer Registries of the Scandinavian countries contin-
uously collect high-quality data on patient characteris-
tics, treatments and outcomes, and provide data for
events with low frequency on a larger scale compared to
more limited data at an institutional level. As national
cancer registries do not provide follow-up data of indi-
vidual patients, they report relative survival outcomes as
a well-accepted measure of cancer-specific survival [13].
The aim of this study was to investigate the impact
of anastomotic leak Grade C on long-term colon-can-
cer-specific survival, expressed by relative survival, in
patients according to stage of disease.
Methods
Ethics
The Regional Ethical Review Board at Karolinska Insti-
tutet approved this study in Sweden (2016/146-31). In
Norway, the study was conducted under the regulations
of the Cancer Registry of Norway; in Denmark, the
study was classified as a quality assurance project using
anonymous data, and so not under the mandate of the
Regional Ethics Committee in Norway or the Danish
Data Protective Agency.
Data were reported and collected according to the
governmental regulations for the Colorectal Cancer
Registries of Sweden, Norway and Denmark. All patient
records were assembled without any person-identifying
information, excluding the possibility of backward iden-
tification.
Study design and data collection
The present study used data from the dedicated
Colorectal Cancer Registries of Sweden, Norway and
Denmark to investigate anastomotic leak rates and the
impact on relative survival. A unique personal identifica-
tion number assigned to all residents in these countries
facilitated effective and reliable identifying and tracking
of patients, record linkage and exclusion of duplicates
across registries.
All patients with a first-time diagnosis of Union
for International Cancer Control (UICC) Stage I–III
colon cancer who underwent surgical resection with
primary anastomosis between 1 January 2008 and 31
December 2012 were included. Patients who had
undergone a protective proximal loop-stoma or a ter-
minal stoma or those with incomplete data on cancer
stage or unknown surgical approach were excluded.
The study is reported according to the STROBE
guidelines [14].
The Scandinavian cancer registries
The cancer registries of Sweden, Norway and Denmark
were established in 1958, 1953 and 1943, respectively,
and dedicated national quality registries for colorectal
cancer were established between 1995 and 2007. These
quality registries record detailed data on diagnosis and
treatment and have resulted in numerous scientific stud-
ies as well as annual governmental reports on national
quality measures for cancer treatment [15–17]. Report-
ing to the colorectal cancer registries is compulsory in
Scandinavia. All patients with a first-time diagnosis of
colorectal cancer are registered, ensuring high data
quality and reliability, in addition to a patient complete-
ness above 95%, as previously documented [18–20].
Complete follow-up is secured by a unique personal
number for all inhabitants of the Scandinavian countries
(10-digit in Denmark and Sweden, 11-digit in Nor-
way).
Outcome measures
Primary outcome was 5-year relative survival and condi-
tional relative survival, conditional on surviving the first
year, stratified by stage of disease. In order to capture
the impact of anastomotic leak, survival was estimated
from the day of surgery until the end of follow-up at
5 years.
Relative survival was estimated up to 5 years after
surgery and defined as the ratio between survival in
patients included in the study and the survival expected
in a general population with the same age, sex, year of
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birth and nationality distribution as the patient cohort.
Accordingly, relative survival estimates the mortality
that is related to the diagnosis and treatment of colon
cancer. To further evaluate the long-term impact of
anastomotic leak, relative survival, conditional on surviv-
ing the first year, was also assessed. This approach limits
relative survival analysis to those patients who had sur-
vived the first year post-surgery, thus eliminating the
influence of early mortality during the first year
[21,22]. Data on survival for the general Swedish, Nor-
wegian and Danish populations were collected from
population life tables in the Human Mortality Database
[23].
Anastomotic leak was defined as a communication
between the intraluminal and extraluminal compart-
ments through the anastomotic line confirmed by reop-
eration under general anaesthesia, corresponding to a
Grade C leak as recommended by the International
Study Group of Rectal Cancer and to Clavien–Dindo
complication Grade IIIb or higher [24,25]. Currently,
no specific recommendations for the grading of anasto-
motic leak after colon resections exist, and the assump-
tion was made that this classification applies equivalently
for colon and rectal resections.
Patients, staging and variable definitions
Patient demographics, tumour characteristics and treat-
ment factors were consecutively recorded in the national
colorectal cancer registries and merged with data on
patient survival or death. By using the same predefined
definitions for each variable and variable value, inherent
national differences were minimized.
Patients were subdivided into three groups by age:
< 65 years, 65–79 years and ≥ 80 years. Comorbidity
was addressed using the American Society of Anesthesi-
ologists (ASA) score [26], categorized as I–II, III and
IV–V. The Norwegian and Danish patient data were
linked to each country’s national patient registry to cal-
culate the Charlson Comorbidity Index (CCI), catego-
rized as scores of 0, 1–2 and> 2 [27]. Such coupling
was not performed for Swedish patients, so the CCI
was not available for the Swedish cohort.
Cancer stage was classified according to the 7th
UICC TNM classification, based on findings of preop-
erative CT scan of the chest and abdomen and patho-
logical examinations of the surgical resection specimens
[28]. T stage was categorized as T1–2, T3 and T4. His-
tologically verified lymph node metastases were defined
as N+. The colon was defined as such anatomically from
the appendix to 15 cm above the anal verge. Surgical
procedures were defined as right hemicolectomy, trans-
verse colectomy, left hemicolectomy and sigmoid
colectomy. Surgical approach was defined according to
the intention-to-treat principle: any laparoscopic proce-
dures converted to open surgery were defined as a
laparoscopic approach. Surgical priority was defined as
elective or emergency due to obstruction or perforation
of the colon.
Statistical analysis
The distribution of the duration of follow-up was calcu-
lated using the reverse Kaplan–Meier approach. The
chi-squared test was used to compare categorical vari-
ables between patient groups. Univariable and multi-
variable logistic regression analyses were used to
investigate factors associated with anastomotic leak. In
these analyses Hosmer and Lemeshow’s purposeful vari-
able selection method was used, including testing for
potential interaction effects [29]. As the CCI was
unavailable in the Swedish cohort, it was excluded in
analyses that included all countries. Because of a large
proportion of missing values for ASA scores in the Nor-
wegian cohort, multiple imputation was used to verify
the results of analyses including the ASA score.
Given the large sample size and to partially address
for multiple testing problems with a large number of
tests conducted, a two-tailed P value ≤ 0.010 was con-
sidered to imply a statistically significant effect.
Statistical analyses were done by IBM SPSS Statistics
(IBM Corporation, Armonk, New York, USA) version
23 and R version 3.5.2 [30]. The R-package ‘relsurv’
version 2.2-3 was used for the relative survival calcula-
tions, using the maximum likelihood method for
parameter estimation [31].
Results
A total of 41 981 patients with a first-time diagnosis of
colon cancer were identified, of whom 22 985 (54.8%)
were included according to the eligibility criteria
(Fig. 1). Overall median follow-up was 62.8 months
(interquartile range 46.9–78.4 months). The data com-
pleteness was high, except for missing ASA scores in
3855 patients (16.8%), mostly from the Norwegian
cohort (40.2%, Table S1).
Patient characteristics
Patient characteristics are shown for the entire patient
cohort and by stages (Table 1). Some variations in dis-
tribution of age, burden of comorbidity, tumour site,
tumour stage, proportion of patients treated as an
emergency, and rate of laparoscopic treatment between
countries were seen (Table S1).
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Characteristic of anastomotic leaks
A total of 849 (3.7%) patients developed an anastomotic
leak (Table 1). This was significantly more frequent in
the Danish cohort (5.3%) compared with the Norwe-
gian (3.0%, P < 0.001) or the Swedish cohort (3.1%,
P < 0.001) (Table S1). Factors associated with
increased risk of anastomotic leak are shown in Table 2.
Multivariable analysis revealed that male gender, Stage
II disease, higher ASA score and resections beyond the
right flexure were significantly associated with anasto-
motic leak. Resections in octagenarians and nonagenari-
ans were associated with lower risk of anastomotic leak.
These results were confirmed by multiple imputation
accounting for the missing data on the ASA score
(Table S1).
Relative survival
Overall, 5-year relative survival was 87.0%, and differed
significantly between stages (Stage I, 99.9%; Stage II,
94.1%; Stage III, 72.2%; P < 0.001). Anastomotic leak
was associated with a lower 5-year relative survival in
the entire cohort (64.7%; P < 0.001; Fig. 2). During
the first year after surgery, mortality was highest, and
relative survival was 77.8%, similar in all stages (Stage I,
83.4%; Stage II, 77.6%; Stage III, 75.4%; P = 0.373).
Conditional relative survival
Conditional relative survival after 5 years, conditional
on surviving the first year after surgery, was 89.9 % in
all patients (90.1 % in those without leak and 82.1 % in
patients with anastomotic leak) (Table 3; P = 0.003).
Conditional relative survival stratified by stage showed
that patients with Stage III disease and anastomotic leak
had a significantly lower survival after 5 years than those
who had not experienced anastomotic leak (63.5% and
79.0%, P = 0.001, Table 3, Fig. 2). Anastomotic leak in
patients with Stage I and II disease was not associated
with reduced conditional relative 5-year survival
(Table 3, Fig. 2). Stratification for age groups, i.e. 75
or 80 years, showed similar results.
Discussion
Anastomotic leak is one of the most serious complica-
tions following colon resections and has a grave impact
on patients’ physical and mental health [32,33]. This
study found a total of 849 anastomotic leaks (3.7%) in
22 985 patients resected for colon cancer Stage I–III.
This was associated with a reduced 5-year relative sur-
vival in patients with Stage III colon cancer. The cohort
is double the size reported in a recent meta-analysis
dealing with long-term outcomes after anastomotic leak
following colorectal resections which concluded that
data on long-term cancer-specific survival for colon can-
cer patients with anastomotic leak are lacking [11].
This study uses a high-quality dataset with complete
follow-up, secured by unique national personal identifi-
cation numbers and official death statistics. Anastomotic
leak was associated with highly significant short-term
mortality up to 1 year after treatment. In other studies,
short-term mortality is usually reported as 90-day mor-
tality since most patients who are ill after anastomotic
leak are successfully treated and survive far beyond
30 days post-surgery. It is important to recognize that
anastomotic leak mortality occurs beyond the first 3
months and throughout the first year (Fig. 2).
More importantly, the study reveals a strong negative
impact on long-term relative survival following anasto-
motic leak after curative resection for colon cancer. In
contrast to overall survival, relative survival reflects the
survival related to a diagnosis and treatment of a given
disease compared to the survival estimates of a matched
background population [34]. Relative survival is a useful
statistical tool for assessment of differences in survival
and for adjustment of the different expected survival
rates in respective general populations and relates closely
to cancer-specific survival [35]. Other large registries
have used this measurement as the equivalent of cancer-
Patients enrolled in the study
n = 22 985 (54·8%)a
UICC I
n = 3772 (16·4%)
UICC II
n = 10 820 (47·1%)
UICC III
n = 8393 (36·5%)
All patients diagnosed with colon cancer
2008–2012, n = 41 981
n = 29 247
Treatment with stoma, n = 2575
n = 26 672
No surgical treatment/excluded procedures, n = 3 687
UICC IV/UICC unknown, n =12 734
Figure 1 Flowchart of patients with colon cancer registered at
the Colorectal Cancer Registries in Sweden, Norway and Den-
mark during the years 2008–2012. Patients who underwent
resection for colon cancer Stage I–III were included in the
analysis. Detailed figures for each country are shown in
Table S1. aPercentage of all patients.
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specific survival, since this approach eliminates mortality
from other causes [36,37]. The use of conditional 1-
year relative survival analysis eliminates the mortality
due to anastomotic leak during the first year [21,22].
This approach describes the mortality during the
remaining 4 years of the total 5-year follow-up, and
depicts the true long-term mortality related to Grade C
anastomotic leak. The results of our study show that
conditional 1-year relative survival was significantly
reduced compared with patients who did not develop
an anastomotic leak. This increased late mortality was
statistically significant for patients with Stage III disease
compared to Stage I or II (Table 3, Fig. 2).
The reasons for impaired long-term survival among
Stage III patients with anastomotic leak are unclear. The
event of anastomotic leak may possibly enforce the
adverse impact of Stage III disease on the biological
course of the cancer disease, lymph node involvement
Table 1 Characteristics of 22 895 patients surgically resected for colon cancer Stage I–III.
Stage I Stage II Stage III All stages
Pn % n % n % n %
Total 3772 16.4 10 820 47.1 8393 36.5 22 985 100.0
AL
Leak 107 2.8 445 4.1 297 3.5 849 3.7 0.0011
No leak 3665 97.2 10 375 95.6 8096 96.5 22 136 96.3
Sex
Female 2007 53.2 5739 53.0 4483 53.4 12 229 53.2 0.8763
Male 1765 46.8 5081 47.0 3910 46.6 10 756 46.8
Age
< 65 779 20.7 2223 20.5 2186 26.0 5188 22.6 < 0.0001
65–79 1903 50.5 5276 48.8 4041 48.1 11220 48.8
> 79 1090 28.9 3321 30.7 2166 25.8 6577 28.6
Country
Sweden 1777 47.1 4611 42.6 3961 47.1 10 349 45.0 < 0.0001
Norway 973 25.8 2875 26.6 2019 24.1 5867 25.5
Denmark 1022 27.8 3334 30.8 2413 28.8 6769 29.4
ASA score
I–II 2233 70.9 6089 68.4 5111 72.2 13 433 58.4 < 0.0001
III 852 27.1 2593 29.1 1825 25.8 5270 22.9
IV–V 63 2.0 217 2.4 147 2.1 427 1.9
Missing 3855 16.8
Charlson
0 1155 58.4 3774 61.0 2766 62.7 7695 33.5 0.0109
1–2 632 32.0 1829 29.6 1287 29.2 3748 16.3
> 2 190 9.6 583 9.4 362 8.2 1135 4.9
Missing 10 407 45.3
Procedure
Right 2021 53.9 6531 60.4 5027 59.9 13 579 59.1 < 0.0001
Transverse 73 1.9 258 2.4 174 2.1 505 2.2
Left 376 10.0 1324 12.2 1003 12.0 2703 11.8
Sigmoid 1302 34.5 2707 25.0 2189 26.1 6198 27.0
Approach
Open 2424 64.5 7.951 73.6 6344 75.8 16 719 72.7 < 0.0001
Laparoscopic 1337 35.5 2.845 26.4 2030 24.2 6212 27.0
Missing 54 0.2
Priority
Elective 3541 96.4 9.363 88.8 6883 84.2 19 787 86.1 < 0.0001
Emergency 133 3.6 1.186 11.2 1288 15.8 2607 11.3
Missing 591 2.6
AL, anastomotic leak; ASA, American Society of Anesthesiologists.
P value of the Pearson chi-squared test of differences between stages.
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being one of the strongest negative prognostic factors for
patients with potentially curable colon cancer [38,39].
Other new concepts like the role of the microbiome in
the bowel on this tumour–host relationship may give
important clues to a better understanding of the impact
of anastomotic leak on treatment outcomes [40].
The health consequences of a Grade C anastomotic
leak may mean that the patient is unfit for adjuvant
chemotherapy and, even if given, that its efficacy may
be reduced [1,3,4,9]. According to a recent study, in
44% of the patients who started adjuvant chemotherapy,
planned doses and/or duration had to be changed due
Table 2 Multiple logistic regression of possible independent factors influencing the occurrence of anastomotic leak after surgery for
colon cancer Stages I–III.
Univariable Multivariable
OR P CI OR P CI
Gender
Female Ref. Ref.
Male 1.76 < 0.001 1.47–2.12 1.50 < 0.001 1.23–1.84
Age < 0.001
<65 Ref. 0.002 Ref.
65–79 0.92 0.323 0.74–1.14 0.85 0.088 0.67–1.09
>79 0.72 0.001 0.55–0.93 0.64 < 0.001 0.47–0.86
T stage
T1 Ref. 0.002
T2 0.82 0.324 0.82–1.37
T3 1.23 0.226 0.80–1.90
T4 1.36 0.090 0.85–2.19
N stage
N0 Ref.
N+ 0.93 0.310 0.77–1.21
UICC < 0.001
I Ref. 0.032 Ref.
II 1.32 0.011 1.11–2.31 1.59 < 0.001 1.17–2.17
III 1.57 0.017 1.09–2.27 1.31 0.034 0.94–1.81
Charlson Comorbidity Index
0 Ref. 0.973
1–2 0.97 0.835 0.65–1.45
> 2 0.98 0.913 0.64–1.51
ASA score < 0.001
I–II Ref. < 0.001 Ref.
III 1.44 < 0.001 1.17–1.77 1.61 < 0.001 1.29–2.01
IV–V 1.95 0.001 1.15–3.30 2.29 < 0.001 1.33–3.91
Priority
Elective Ref.
Emergency 1.11 0.340 0.84–1.45
Approach
Open Ref.
Laparoscopic 1.08 0.334 0.88–1.32
Procedure < 0.001
Right Ref. < 0.001 Ref.
Transverse 2.35 < 0.001 1.45–3.81 2.32 < 0.001 1.34–4.00
Left 1.84 < 0.001 1.42–2.38 1.91 < 0.001 1.45–2.52
Sigmoid 1.62 < 0.001 1.32–1.98 1.66 < 0.001 1.32–2.08
ASA, American Society of Anesthesiologists; UICC, Union for International Cancer Control. Method forward (WALD).
Patients included 19 033; patients with missing ASA score excluded. Charlson Comorbidity Index not included for analysis. Good-
ness-of-fit P = 0.875 in step 5 (by Homer and Lemeshow test). Variables excluded in final analysis: T stage P = 0.145, N stage
P = 0.343, priority P = 0.302 and approach P = 0.206. No significant interactions were found.
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Figure 2 Relative 5-year survival (above) and conditional relative survival (below), conditional on having survived the first year after
surgery, of patients resected for colon cancer with regard to anastomotic leak and stratified by Stage I, II or III. Conditional relative
survival of patients with anastomotic leak was significantly lower compared to those without leak in Stage III (P ˂ 0.001), but not
in patients with Stage I or II (Table 3).
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to various adverse events, which render the adjuvants
less effective [41]. The possible relationship between
adjuvant chemotherapy and impaired survival in Stage
III after anastomotic leak is a very complex issue. Based
on the recommendation of adjuvant chemotherapy for
patients with Stage III disease up to 75 years, and even-
tually 80 years, conditional relative survival analysis
stratified by stage was also performed as a sensitivity
analysis with regard to age below or above 75 and
80 years as a proxy for the use of chemotherapy. These
analyses did not reveal any differences to the dataset
with all patients (data not shown). Highly granular data
on type of drug, duration, dose adjustments or other
factors do not exist in the registries for the study per-
iod. Moreover, these data are complex and do not allow
simple dichotomization of treatment given into adju-
vant treatment given or not. This topic poses method-
ological challenges that cannot be met by large national
datasets but need appropriately designed prospective
studies. Serious complications including anastomotic
leak after surgery have recently been identified as a sig-
nificant predictor for delayed return to work and this
observation underlines the serious impact of anasto-
motic leak on the individual patient [42].
Only 3%–4% of patients develop an anastomotic leak
after colonic resection. This usually represents a low
number of patients in any series and it is therefore diffi-
cult to corroborate the association between anastomotic
leak and impaired long-term outcomes. A recent single
centre study found only one recurrence among 12 of
445 patients with anastomotic leak, while H€uttner et al.
reported 26 patients with anastomotic leak in a series of
628, thus underlining the need for large-scale popula-
tion-based analyses [10,43]. Impaired overall survival
was demonstrated in a Japanese cohort of 4919 patients
and suggested an increased risk of local recurrence asso-
ciated with anastomotic leak, but in contrast to a Dan-
ish study there was no association with distant
metastases in the Japanese cohort [3,9]. In their meta-
analysis, Mirnezami et al. showed increased rates of
local recurrences after anastomotic leak following resec-
tions for rectal cancer but inconclusive for colon cancer
and similarly for the risk of distant spread [4].
The present analysis of 22 985 patients, based on
national data from three countries covering a popula-
tion of 18 million, reports on 849 patients with anasto-
motic leak, enabling reliable outcomes due to high-
quality national registries with clear definitions of vari-
ables and complete follow-up based on unique personal
identifiers. The observations of inferior long-term out-
come after anastomotic leak associated with the sub-
group of patients with Stage III disease are founded on
large numbers, strongly supporting the idea of an unfa-
vourable relation between anastomotic leak and patients
with metastatic lymph nodes. National cancer registries
notoriously do not provide detailed data on recurrent
disease, something more achievable in institutional ser-
ies. However, the observation of impaired long-term
Table 3 Long-term relative survival and relative conditional survival (conditional on having survived 1 year after surgery) at differ-
ent time intervals (years), with regard to anastomotic leak.
Relative survival Conditional relative survival
1 years 2 years 3 years 5 years 1 years 2 years 3 years 5 years
UICC I
Leak 83.4 84.8 87.0 84.5 0.005 100.1 102.5 99.0 0.950
No leak 99.2 99.9 100.4 100.3 100.1 100.0 98.7
Overall 98.8 98.8 100.0 100.0 100.1 100.0 98.7
UICC II
Leak 77.6 74.7 73.8 94.1 <0.001 95.8 94.6 90.4 0.247
No leak 97.2 96.8 96.0 95.0 99.1 97.7 95.2
Overall 96.4 95.9 95.1 71.5 99.0 97.6 95.1
UICC III
Leak 75.4 66.0 58.8 48.2 <0.001 87.5 77.8 63.5 0.001
No leak 90.9 83.5 78.5 73.1 91.5 85.8 79.0
Overall 90.3 82.8 77.8 72.2 91.4 85.5 78.6
UICC I–III
Leak 77.8 73.0 70.2 64.7 <0.001 93.6 90.0 82.1 0.003
No leak 95.2 92.4 90.3 87.9 96.6 93.9 90.1
Overall 94.6 91.7 89.6 87.0 96.5 93.8 89.9
UICC, Union for International Cancer Control.
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relative survival after Grade C anastomotic leak in Stage
III patients translates into impaired long-term cancer-
specific survival. Further studies are needed to elaborate
this association and should include novel concepts on
the molecular or microbiome level.
The present study has a number of limitations. Pop-
ulation-based registry analyses intend to identify associa-
tions but do not aim to reveal causal relationships
between variables. Despite the high accuracy of national
registry data, some variables had considerable missing
values, such as ASA classification or the CCI. While the
former was missing for about 40% of the Norwegian
dataset, CCI was not possible to establish for Swedish
data, limiting analysis to Norway and Denmark. Impu-
tation analyses confirmed the results for analyses includ-
ing ASA score, and introduction of a bias was
considered unlikely. Potential differences in definition,
detection and treatment of anastomotic leak might rep-
resent a further limitation [44].
Only patients surgically treated for anastomotic leak,
i.e. Clavien–Dindo Grade IIIb complication, were
included in the present cohort. This enables a robust
analysis. Valid data indicating conservative treatment or
minimally invasive procedures, e.g. percutaneous drai-
nage, are difficult to obtain and were not registered.
Consequently, this analysis may underestimate the total
incidence of anastomotic leak. However, the definition
of Grade C anastomotic leak secures unequivocal data
on anastomotic leak and contributes to better compara-
bility with other studies, and our results apply for this
patient group.
One might argue that an anastomotic leak requiring
reoperation could have a stronger impact on long-term
outcomes. These patients represent the core population
to experience this potentially lethal complication with
strongest impact on physiology and the need for rapid
reoperation. This is expressed by Grade IIIb or higher
on the Clavien-Dindo complication scale compared to
patients with a subclinical course of anastomotic leak
(Grade A) or who are treated with percutaneous drai-
nage of an abscess related to the anastomosis with mini-
mal leak (Grade B). The definition of subclinical
anastomotic leak is challenging within a large dataset
such as ours and has been described as divergent [11].
In conclusion, relative survival analysis showed a
strong negative impact of anastomotic leak on long-
term outcomes in patients resected for colon cancer and
translates into impaired cancer-specific survival. The
results of this study highlight the detrimental impact of
anastomotic leak after surgery for colon cancer in partic-
ular on patients with Stage III disease. Further efforts
are needed to better understand the development and
prevention of this serious complication.
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